NYSE: CVS | Healthcare / Healthcare Plans / USA |
68.48 | +0.5300 | +0.78% | Vol 6.98M | 1Y Perf -33.21% |
Dec 1st, 2023 16:00 DELAYED |
BID | 68.25 | ASK | 68.58 | ||
Open | 67.91 | Previous Close | 67.95 | ||
Pre-Market | - | After-Market | 68.50 | ||
- - | 0.02 0.03% |
Target Price | 117.25 | Analyst Rating | Moderate Buy 1.60 | |
Potential % | 71.22 | Finscreener Ranking | ★ 40.97 | |
Insiders Trans % 3/6/12 mo. | -100/-89/-79 | Value Ranking | ★ 39.01 | |
Insiders Value % 3/6/12 mo. | -100/-99/-98 | Growth Ranking | ★+ 42.32 | |
Insiders Shares Cnt. % 3/6/12 mo. | -100/-99/-98 | Income Ranking | ★ 30.45 | |
Price Range Ratio 52W % | 10.07 | Earnings Rating | Sell | |
Market Cap | 88.13B | Earnings Date | 1st Nov 2023 | |
Alpha | -0.00 | Standard Deviation | 0.07 | |
Beta | 0.58 |
Today's Price Range 67.3768.64 | 52W Range 64.41104.83 | 5 Year PE Ratio Range -89.2019.20 |
Summary:
Sell
Technical Indicators: | Neutral |
Moving Averages: | Strong Sell |
Performance | |||
---|---|---|---|
1 Week | -1.35% | ||
1 Month | -1.67% | ||
3 Months | 4.28% | ||
6 Months | -2.16% | ||
1 Year | -33.21% | ||
3 Years | -1.65% | ||
5 Years | -14.61% | ||
10 Years | 5.69% |
Mngmt Effectiveness | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
ROE (5Y Avg) | 7.61 | |||
ROE last 12 Months | 4.72 | |||
ROA (5Y Avg) | 1.85 | |||
ROA last 12 Months | 1.47 | |||
ROC (5Y Avg) | 5.28 | |||
ROC last 12 Months | 3.37 | |||
Return on invested Capital Q | -2.05 | |||
Return on invested Capital Y | 1.19 | |||
Assets Turnover | 1.10 | |||
Receivables Turnover | 10.00 |
Valuation | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
39.10 | ||||
1.70 | ||||
0.50 | ||||
5.50 | ||||
10.20 | ||||
16.67 | ||||
-3.70 | ||||
53.79 | ||||
171.44B | ||||
Forward PE | 8.12 | |||
PEG | 8.69 |
Financial Strength | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
0.60 | ||||
0.90 | ||||
0.49 | ||||
1.01 | ||||
2.70 | ||||
Leverage Ratio | 3.20 |
Profitability | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
17.20 | ||||
2.00 | ||||
3.40 | ||||
2.90 | ||||
0.78 |
Revenue | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
238.62B | ||||
181.60 | ||||
9.47 | ||||
11.35 |
Dividends | Value | Industry | S&P 500 | US Markets |
---|---|---|---|---|
2.65 | ||||
2.42 | ||||
0.24 | ||||
1.44 | ||||
Payout ratio | 35.00 |
Earnings History | Estimate | Reported | Surprise % |
---|---|---|---|
Q03 2023 | 2.13 | 2.21 | 3.76 |
Q02 2023 | 2.12 | 2.21 | 4.25 |
Q01 2023 | 2.07 | 2.20 | 6.28 |
Q04 2022 | 1.92 | 1.99 | 3.65 |
Q03 2022 | 1.99 | 2.09 | 5.03 |
Q02 2022 | 2.16 | 2.40 | 11.11 |
Q01 2022 | 2.14 | 2.22 | 3.74 |
Q04 2021 | 1.94 | 1.98 | 2.06 |
Earnings Per End | Estimate | Revision % | Trend |
---|---|---|---|
12/2023 QR | 1.98 | -2.94 | Negative |
12/2023 FY | 8.59 | -0.12 | Negative |
3/2024 QR | 2.04 | -5.12 | Negative |
12/2024 FY | 8.54 | -1.95 | Negative |
Next Report Date | - |
Estimated EPS Next Report | 2.13 |
Estimates Count | 11 |
EPS Growth Next 5 Years % | 4.50 |
Volume Overview | |
---|---|
Volume | 6.98M |
Shares Outstanding | 1.29M |
Shares Float | 1.07B |
Trades Count | 74.69K |
Dollar Volume | 476.71M |
Avg. Volume | 6.89M |
Avg. Weekly Volume | 6.65M |
Avg. Monthly Volume | 6.94M |
Avg. Quarterly Volume | 7.10M |
CVS Health Corporation (NYSE: CVS) stock closed at 68.48 per share at the end of the most recent trading day (a 0.78% change compared to the prior day closing price) with a volume of 6.98M shares and market capitalization of 88.13B. Is a component of S&P 500, Russell 1000 indices and it is traded on NYSE exchange. The company belongs in the Healthcare Plans industry, Healthcare sector and employs 300000 people. CVS Health Corporation CEO is Karen S. Lynch.
The one-year performance of CVS Health Corporation stock is -33.21%, while year-to-date (YTD) performance is -26.52%. CVS stock has a five-year performance of -14.61%. Its 52-week range is between 64.41 and 104.83, which gives CVS stock a 52-week price range ratio of 10.07%
CVS Health Corporation currently has a PE ratio of 39.10, a price-to-book (PB) ratio of 1.70, a price-to-sale (PS) ratio of 0.50, a price to cashflow ratio of 5.50, a PEG ratio of 8.69, a ROA of 1.47%, a ROC of 3.37% and a ROE of 4.72%. The company’s profit margin is 0.78%, its EBITDA margin is 3.40%, and its revenue ttm is $238.62 Billion , which makes it $181.60 revenue per share.
Of the last four earnings reports from CVS Health Corporation, there were 4 positive earnings surprise and 0 negative earnings surprise. The company has EPS estimate of $2.13 for the next earnings report. CVS Health Corporation’s next earnings report date is -.
The consensus rating of Wall Street analysts for CVS Health Corporation is Moderate Buy (1.6), with a target price of $117.25, which is +71.22% compared to the current price. The earnings rating for CVS Health Corporation stock is Sell (calculated from actual period earnings estimates revision (80% weight) and previous period earnings surprise (20% weight)).
CVS Health Corporation has a dividend yield of 2.65% with a dividend per share of $2.42 and a payout ratio of 35.00%.
CVS Health Corporation has a Sell technical analysis rating based on Technical Indicators (ADX : 8.38, ATR14 : 1.42, CCI20 : -44.96, Chaikin Money Flow : 0.06, MACD : -0.30, Money Flow Index : 53.70, ROC : 1.00, RSI : 48.64, STOCH (14,3) : 67.53, STOCH RSI : 0.69, UO : 57.59, Williams %R : -32.48), Simple Moving Averages and Exponential Moving Averages.
Aggregated Insider Trades of CVS Health Corporation in the last 12-months were: Karen S. Lynch (Buy at a value of $976 500), Ludwig Edward (Buy at a value of $140 940), Thomas M. Moriarty (Option Excercise at a value of $10 151 220), Thomas M. Moriarty (Sold 137 466 shares of value $13 521 179 )
Analyst Ratings | Current | 1 M ago | 3 M ago |
---|---|---|---|
Strong Buy | |||
Moderate Buy | |||
Hold | |||
Moderate Sell | |||
Strong Sell | |||
Summary Rating | Moderate Buy | Moderate Buy | Moderate Buy |
Following its acquisition of Aetna in late 2018, CVS Health now provides an even more integrated healthcare-services offering for its members. Legacy CVS combined both the largest pharmacy benefit manager, processing over 2 billion adjusted claims annually, and a sizable pharmacy operation, including nearly 10,000 retail pharmacy locations primarily in the U.S. Adding a managed-care organization with over 23 million medical members gives the company a strong position in the insurance industry and should help CVS better control overall healthcare costs for its clients.
CEO: Karen S. Lynch
Telephone: +1 401 765-1500
Address: One CVS Drive, Woonsocket 02895, RI, US
Number of employees: 300 000
Mon, 20 Nov 2023 13:33 GMT Analysts Have Conflicting Sentiments on These Healthcare Companies: CVS Health (CVS), Madrigal Pharmaceuticals (MDGL) and VolitionRX (VNRX)
- TipRanks. All rights reserved.Mon, 20 Nov 2023 13:21 GMT Analysts Offer Insights on Healthcare Companies: CVS Health (CVS), UnitedHealth (UNH) and Accuray (ARAY)
- TipRanks. All rights reserved.Fri, 08 Sep 2023 06:26 GMT CVS Health (CVS) Receives a Buy from Mizuho Securities
- TipRanks. All rights reserved.Mon, 07 Aug 2023 07:20 GMT Analysts Offer Insights on Healthcare Companies: CVS Health (CVS) and Gilead Sciences (GILD)
- TipRanks. All rights reserved.Copyright © 2016-2023 Finscreener.org. All Rights Reserved.
Disclaimer: Before deciding to trade you should carefully consider your investment objectives, level of experience and your risk appetite. Forex data is a real-time with a 30 second refresh. Prices may not be accurate and may differ from the actual market price. Prices on the website are indicative and solely for informational purposes, not for trading purposes or advice. Please be aware of the risks associated with trading the on financial markets, it is one of the riskiest investment forms. Past performance does not guarantee future profits. We take no responsibility for any losses that may arise as a result of the data contained on this website. The content and the website are provided "as is", without any warranties. In no event will Finscreener.org, its employees, owners, directors, affiliates, partners, data provider, third party or anyone else liable to anyone else for any decision made regarding information on this website.
All rights reserved. Financial Market Data powered by Quotemedia.com. All rights reserved. View the Terms of Use. NYSE/NYSE MKT (AMEX) data delayed 20 minutes. NASDAQ and other data delayed 15 minutes unless otherwise indicated. Copyright © 2023. All market data is provided by Quotemedia.com. Futures: at least a 10 minute delay. Information is provided 'as is' and solely for informational purposes, not for trading purposes or advice. To see all exchange delays and terms of use, please see disclaimer.
General partner of Finscreener is SLOVAKODATA, a.s.
Don´t have an account? Register
Looks like you are using AdBlock.
The revenue earned from advertising enables us to provide the quality content you are trying to reach on this website. In order to view this page, please disable AdBlock or purchase Premium.
Sign in if you already have Premium account.
This could take some time, please wait.